One major hurdle is the presence of resistance in individuals with obesity, such as leptin resistance and FGF21 resistance, which reduces responsiveness to the metabolically favorable actions of these adipokines. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.